Clinical Trial Update: TUDCA in High-Risk Lactating Mothers Identified by Early Postpartum Milk Hydrophobicity Index [Phase 2]

View source ↗

Summary

Phase 2 trial investigating tauroursodeoxycholic acid (TUDCA) in high‑risk lactating mothers identified by an early postpartum milk hydrophobicity index, focusi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Dysfunction-associated Steatotic Liver Disease

Drugs mentioned

• TUDCA (Tauroursodeoxycholic acid)

Snippet

Sponsor: Peking University First Hospital | Conditions: Metabolic Dysfunction-Associated Steatotic Liver Disease Infant Development | Phase 2 | Status: NOT_YET_RECRUITING